Nicolas Girard
Nicolas Girard (born June 5, 1972 in Montreal, Quebec) is a politician in Quebec, Canada, and former member of the National Assembly of Quebec. He was elected to the National Assembly in a by-election as a Parti Québécois member on September 20, 2004 in riding of Gouin in the Montreal region. Provided by Wikipedia
Showing 1 - 20 results of 58 for search 'Nicolas Girard', query time: 0.06s
Refine Results
-
1
Thymic epithelial tumours: from basic principles to individualised treatment strategies by Nicolas Girard
Published 2013-03-01
Article -
2
Topics in thoracic oncology: from surgical resection to molecular dissection by Nicolas Girard, Gérard Zalcman
Published 2013-06-01
Article -
3
-
4
Strategies of Lymph Node Dissection During Sublobar Resection for Early-Stage Lung Cancer by Dominique Gossot, Alessio Vincenzo Mariolo, Marine Lefevre, Guillaume Boddaert, Emmanuel Brian, Madalina Grigoroiu, Nicolas Girard, Nicolas Girard, Agathe Seguin-Givelet, Agathe Seguin-Givelet
Published 2021-09-01
Article -
5
Hadrontherapy for Thymic Epithelial Tumors: Implementation in Clinical Practice by Pierre Loap, Pierre Loap, Viviana Vitolo, Amelia Barcellini, Ludovic De Marzi, Ludovic De Marzi, Alfredo Mirandola, Maria Rosaria Fiore, Barbara Vischioni, Barbara Alicja Jereczek-Fossa, Barbara Alicja Jereczek-Fossa, Nicolas Girard, Nicolas Girard, Nicolas Girard, Youlia Kirova, Ester Orlandi
Published 2021-10-01
Article -
6
Nasopharyngeal sialocoele with underlying auditory tube neoplasia in a cat by Julien Fritz, Audrey Belmudes, Edouard Cauvin, Nicolas Girard, Delphine N Rault
Published 2022-08-01
Article -
7
Chemotherapy Definitions and Policies for Thymic Malignancies by Nicolas Girard, Rohit Lal, Heather Wakelee, Gregory J. Riely, Patrick J. Loehrer
Published 2014-02-01
Article -
8
-
9
-
10
-
11
3-Deazaneplanocin A (DZNep), an inhibitor of the histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells. by Nicolas Girard, Céline Bazille, Eva Lhuissier, Hervé Benateau, Antonio Llombart-Bosch, Karim Boumediene, Catherine Bauge
Published 2014-01-01
Article -
12
The Antitumoral Effect of the S-Adenosylhomocysteine Hydrolase Inhibitor, 3-Deazaneplanocin A, is Independent of EZH2 but is Correlated with EGFR Downregulation in Chondrosarcomas by Juliette Aury-Landas, Nicolas Girard, Eva Lhuissier, Drifa Adouane, Raphael Delépée, Karim Boumediene, Catherine Baugé
Published 2019-10-01
Article -
13
-
14
-
15
-
16
-
17
Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature by Marcela Carausu, Arnaud Beddok, Adriana Langer, Nicolas Girard, François-Clément Bidard, Marie-Ange Massiani, Damien Ricard, Luc Cabel
Published 2019-11-01
Article -
18
Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma. by Vasily N Aushev, Irina B Zborovskaya, Konstantin K Laktionov, Nicolas Girard, Marie-Pierre Cros, Zdenko Herceg, Vladimir Krutovskikh
Published 2013-01-01
Article -
19
Gain of Aggressive Histological and Molecular Patterns after Acquired Resistance to Novel Anti-EGFR Therapies in Non-Small Cell Lung Cancer by Clémence Basse, Olfa Trabelsi-Grati, Julien Masliah, Céline Callens, Maud Kamal, Paul Freneaux, Jerzy Klijanienko, Ivan Bieche, Nicolas Girard
Published 2023-02-01
Article -
20